Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPROPION vs BUROSUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPROPION vs BUROSUMAB: Safety Overview

Metric BUPROPION BUROSUMAB
Total FAERS Reports 35,634 674
Deaths Reported 8,577 6
Death Rate 24.1% 0.9%
Hospitalizations 10,246 111
Average Patient Age 44.6 yrs 37.3 yrs
% Female Patients 70.7% 50.0%
FDA Approval Date Apr 12, 2017 N/A
Manufacturer NuCare Pharmaceuticals, Inc. Kyowa Kirin, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued N/A